This invention relates to a series of new fluorinated endogenous isoquinoline-mimicking compounds intended for use in the process of preparing valuable dietary supplements and pharmaceuticals as well as research tools for a wide range of medical, psychiatric and/or neurological conditions. The new compounds can be synthesized using well documented reactions and commercially available starting materials.
